KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Total Liabilities (2020 - 2025)

Historic Total Liabilities for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $5.3 billion.

  • Oscar Health's Total Liabilities rose 3976.4% to $5.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.3 billion, marking a year-over-year increase of 3976.4%. This contributed to the annual value of $5.3 billion for FY2025, which is 3976.4% up from last year.
  • Per Oscar Health's latest filing, its Total Liabilities stood at $5.3 billion for Q4 2025, which was up 3976.4% from $4.7 billion recorded in Q3 2025.
  • In the past 5 years, Oscar Health's Total Liabilities ranged from a high of $5.3 billion in Q4 2025 and a low of $1.6 billion during Q3 2021
  • In the last 5 years, Oscar Health's Total Liabilities had a median value of $3.4 billion in 2022 and averaged $3.4 billion.
  • Per our database at Business Quant, Oscar Health's Total Liabilities skyrocketed by 9943.12% in 2022 and then tumbled by 2469.07% in 2023.
  • Quarter analysis of 5 years shows Oscar Health's Total Liabilities stood at $1.9 billion in 2021, then skyrocketed by 88.39% to $3.6 billion in 2022, then decreased by 23.08% to $2.8 billion in 2023, then skyrocketed by 36.8% to $3.8 billion in 2024, then surged by 39.76% to $5.3 billion in 2025.
  • Its Total Liabilities was $5.3 billion in Q4 2025, compared to $4.7 billion in Q3 2025 and $5.2 billion in Q2 2025.